FDA recall record

Genentech CellCept (mycophenolate mofetil) capsules, 250 mg recall — FDA D-097-2013

Short Fill: some bottles contained less than 120-count per labeled claim.

Class IIIclassification
D-097-2013official record ID
Dec 26, 2012report date

Recall record at a glance

Official recordD-097-2013
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmGenentech, Inc.
Report dateDec 26, 2012
Recall initiation dateSep 27, 2012
Quantity1128 bottles
LocationSouth San Francisco, CA, United States

Official product description

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Why the product was recalled

Short Fill: some bottles contained less than 120-count per labeled claim.

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.